Free Trial

Bath & Body Works (BBWI) Financials

Bath & Body Works logo
$20.97 +1.51 (+7.78%)
As of 10:44 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Bath & Body Works

Annual Income Statements for Bath & Body Works

This table shows Bath & Body Works' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Consolidated Net Income / (Loss)
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Net Income / (Loss) Continuing Operations
1,253 1,158 983 644 460 865 1,075 794 878 798 649
Total Pre-Tax Income
1,934 1,696 1,312 857 608 1,122 1,423 1,045 1,021 1,028 882
Total Operating Income
2,192 2,003 1,728 1,237 1,040 1,604 2,009 1,376 1,285 1,266 1,126
Total Gross Profit
5,204 5,125 4,959 4,899 2,387 3,096 3,855 3,255 3,236 3,234 3,189
Total Revenue
12,154 12,574 12,632 13,237 5,405 6,434 7,882 7,560 7,429 7,307 7,291
Operating Revenue
12,154 12,574 12,632 13,237 5,405 6,434 7,882 7,560 7,429 7,307 7,291
Total Cost of Revenue
6,950 7,449 7,673 8,338 3,018 3,338 4,027 4,305 4,193 4,073 4,102
Operating Cost of Revenue
6,950 7,449 7,673 8,338 3,018 3,338 4,027 4,305 4,193 4,073 4,102
Total Operating Expenses
3,012 3,122 3,231 3,662 1,347 1,492 1,846 1,879 1,951 1,968 2,063
Selling, General & Admin Expense
3,012 3,122 3,231 3,563 1,347 1,492 1,846 1,879 1,951 1,968 2,063
Total Other Income / (Expense), net
-258 -307 -416 -380 -432 -482 -586 -331 -264 -238 -244
Interest Expense
334 394 406 385 370 432 388 348 345 312 276
Other Income / (Expense), net
76 87 -10 5.00 -62 -50 -198 17 81 74 32
Income Tax Expense
681 538 329 213 148 257 348 251 143 230 233
Basic Earnings per Share
$4.30 $4.04 $3.46 $2.33 ($1.33) $3.04 $4.96 $3.45 $3.86 $3.62 $3.12
Weighted Average Basic Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Diluted Earnings per Share
$4.22 $3.98 $3.42 $2.31 ($1.32) $3.00 $4.88 $3.43 $3.84 $3.61 $3.11
Weighted Average Diluted Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Weighted Average Basic & Diluted Shares Outstanding
287.08M 287M 284M 276M 276.53M 557.63M 238.91M 228.77M 224.90M 214.23M 201.13M
Cash Dividends to Common per Share
$2.00 $2.40 $2.40 $2.40 $1.20 $0.30 $0.45 $0.80 $0.80 $0.80 $0.80

Quarterly Income Statements for Bath & Body Works

This table shows Bath & Body Works' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Income / (Loss) Attributable to Common Shareholders
119 579 87 152 106 453 105 64 77 403 183
Consolidated Net Income / (Loss)
119 579 87 152 106 453 105 64 77 403 183
Net Income / (Loss) Continuing Operations
119 579 87 152 106 453 105 64 77 403 183
Total Pre-Tax Income
159 623 118 153 145 612 146 95 103 538 166
Total Operating Income
221 695 187 183 218 678 209 157 161 599 231
Total Gross Profit
682 1,336 606 626 700 1,302 646 640 658 1,245 587
Total Revenue
1,562 2,912 1,384 1,526 1,610 2,787 1,424 1,549 1,594 2,724 1,378
Operating Revenue
1,562 2,912 1,384 1,526 1,610 2,787 1,424 1,549 1,594 2,724 1,378
Total Cost of Revenue
880 1,576 778 900 910 1,485 778 909 936 1,479 791
Operating Cost of Revenue
880 1,576 778 900 910 1,485 778 909 936 1,479 791
Total Operating Expenses
461 641 419 443 482 624 437 483 497 646 356
Selling, General & Admin Expense
461 641 419 443 482 624 437 483 497 646 356
Total Other Income / (Expense), net
-62 -72 -69 -30 -73 -66 -63 -62 -58 -61 -65
Interest Expense
84 86 82 77 77 76 71 68 68 69 69
Other Income / (Expense), net
22 14 13 47 4.00 10 8.00 6.00 10 8.00 4.00
Income Tax Expense
40 44 31 1.00 39 159 41 31 26 135 -17
Basic Earnings per Share
$0.52 $2.55 $0.39 $0.68 $0.49 $2.06 $0.49 $0.31 $0.38 $1.94 $0.91
Weighted Average Basic Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Diluted Earnings per Share
$0.52 $2.54 $0.38 $0.68 $0.49 $2.06 $0.49 $0.30 $0.37 $1.95 $0.90
Weighted Average Diluted Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Weighted Average Basic & Diluted Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Cash Dividends to Common per Share
$0.20 - $0.20 $0.20 $0.20 - $0.20 $0.20 $0.20 - $0.20

Annual Cash Flow Statements for Bath & Body Works

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents
867 -614 -419 -102 86 2,434 -1,954 -747 -148 -410 279
Net Cash From Operating Activities
2,027 1,990 1,406 1,377 1,236 2,039 1,492 1,144 954 886 1,102
Net Cash From Continuing Operating Activities
2,027 1,990 1,406 1,377 1,236 2,039 1,492 1,144 954 886 1,102
Net Income / (Loss) Continuing Operations
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Consolidated Net Income / (Loss)
1,253 1,158 983 644 -366 844 1,333 800 878 798 649
Depreciation Expense
457 518 571 590 588 521 363 221 269 282 254
Non-Cash Adjustments To Reconcile Net Income
21 16 127 297 1,147 264 241 38 17 11 23
Changes in Operating Assets and Liabilities, net
338 344 -228 -111 -133 410 -445 85 -210 -205 176
Net Cash From Investing Activities
-443 -833 -698 -609 -480 -219 -259 -328 -286 -162 -227
Net Cash From Continuing Investing Activities
-443 -833 -698 -609 -480 -219 -259 -328 -286 -162 -227
Purchase of Property, Plant & Equipment
-727 -990 -707 -629 -458 -228 -270 -328 -298 -226 -237
Sale of Property, Plant & Equipment
196 53 - - - - - - 0.00 0.00 9.00
Sale and/or Maturity of Investments
59 129 - - - - - 0.00 0.00 40 0.00
Other Investing Activities, net
4.00 8.00 9.00 20 -22 9.00 11 0.00 12 24 1.00
Net Cash From Financing Activities
-716 -1,765 -1,127 -872 -666 610 -3,188 -1,562 -815 -1,132 -599
Net Cash From Continuing Financing Activities
-716 -1,765 -1,127 -872 -666 610 -3,188 -1,562 -815 -1,132 -599
Repayment of Debt
-2.00 -751 -592 -255 -326 -200 -1,716 2.00 -459 -521 -9.00
Repurchase of Common Equity
-483 -435 -446 -198 0.00 0.00 -1,964 -1,312 -148 -401 -401
Payment of Dividends
-1,171 -1,268 -686 -666 -332 -83 -120 -186 -182 -177 -167
Other Financing Activities, net
-55 -38 6.00 -17 -20 -57 612 -66 -26 -33 -22
Effect of Exchange Rate Changes
-1.00 -6.00 0.00 2.00 -4.00 4.00 1.00 -1.00 -1.00 -2.00 3.00

Quarterly Cash Flow Statements for Bath & Body Works

This table details how cash moves in and out of Bath & Body Works' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Change in Cash & Equivalents
-378 672 -229 -341 -323 483 -38 -272 -128 717 -133
Net Cash From Operating Activities
-49 926 76 -46 -99 955 188 -43 80 877 244
Net Cash From Continuing Operating Activities
-49 918 76 -46 -99 955 188 -43 80 877 244
Net Income / (Loss) Continuing Operations
119 579 87 152 106 453 105 64 77 403 183
Consolidated Net Income / (Loss)
119 579 87 152 106 453 105 64 77 403 183
Depreciation Expense
70 70 71 71 69 71 64 64 63 63 61
Non-Cash Adjustments To Reconcile Net Income
-1.00 8.00 12 -27 9.00 16 10 8.00 -1.00 6.00 -49
Changes in Operating Assets and Liabilities, net
-237 261 -94 -242 -283 415 9.00 -179 -59 405 49
Net Cash From Investing Activities
-63 -47 -46 6.00 -74 -48 -39 -56 -72 -60 -42
Net Cash From Continuing Investing Activities
-63 -47 -46 6.00 -74 -48 -39 -56 -72 -60 -42
Purchase of Property, Plant & Equipment
-72 -48 -46 -55 -65 -60 -37 -56 -81 -63 -49
Sale of Property, Plant & Equipment
- - - - - - 0.00 - - - 8.00
Other Investing Activities, net
9.00 1.00 0.00 11 1.00 12 -2.00 - - 3.00 -1.00
Net Cash From Financing Activities
-266 -206 -259 -301 -150 -422 -188 -174 -135 -102 -335
Net Cash From Continuing Financing Activities
-266 -206 -259 -301 -150 -422 -188 -174 -135 -102 -335
Repayment of Debt
-169 -93 -111 -96 -4.00 -308 -5.00 -10 7.00 -1.00 -292
Repurchase of Common Equity
-51 -49 -96 -152 -101 -52 -136 -118 -90 -57 0.00
Payment of Dividends
-45 -45 -45 -45 -44 -43 -43 -42 -41 -41 -40
Other Financing Activities, net
-1.00 -19 -7.00 -8.00 -1.00 -19 -4.00 -4.00 -11 -3.00 -3.00
Effect of Exchange Rate Changes
- - 0.00 - - - 1.00 1.00 -1.00 2.00 0.00

Annual Balance Sheets for Bath & Body Works

This table presents Bath & Body Works' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets
8,493 8,170 8,149 8,090 10,125 11,571 6,026 5,494 5,463 4,872 5,069
Total Current Assets
4,156 3,465 3,293 3,260 3,245 5,579 3,009 2,266 2,115 1,823 2,019
Cash & Equivalents
2,548 1,934 1,515 1,413 1,499 3,568 1,979 1,232 1,084 674 953
Accounts Receivable
261 294 310 367 306 148 240 226 224 205 180
Inventories, net
1,122 1,096 1,240 1,248 1,287 572 709 709 710 734 699
Other Current Assets
225 141 228 232 153 52 81 99 97 114 106
Other Current Nonoperating Assets
- - - - - 1,239 - - 0.00 96 81
Plant, Property, & Equipment, net
2,330 2,741 2,893 2,818 2,486 1,017 1,009 1,193 1,220 1,127 1,127
Total Noncurrent Assets
2,007 1,964 1,963 2,012 4,394 4,975 2,008 2,035 2,128 1,922 1,923
Goodwill
1,318 1,348 1,348 1,348 628 628 628 628 628 628 628
Intangible Assets
411 411 411 411 411 165 165 165 165 165 165
Noncurrent Deferred & Refundable Income Taxes
30 19 14 62 84 58 45 37 144 130 112
Other Noncurrent Operating Assets
248 186 190 191 3,271 1,143 1,170 1,205 1,191 999 1,018
Total Liabilities & Shareholders' Equity
8,493 8,170 8,149 8,090 10,125 11,571 6,026 5,494 5,463 4,872 5,069
Total Liabilities
8,751 8,897 8,900 8,955 11,620 12,232 7,543 7,699 7,089 6,255 6,348
Total Current Liabilities
1,875 2,014 2,031 1,986 2,372 2,826 1,290 1,379 1,289 1,231 1,591
Short-Term Debt
6.00 36 87 72 61 - - - - 0.00 280
Accounts Payable
668 683 717 711 647 345 435 455 380 338 465
Accrued Expenses
977 997 1,029 1,082 1,052 727 651 673 608 584 579
Current Deferred & Payable Income Tax Liabilities
224 298 198 121 134 83 34 74 120 117 72
Other Current Liabilities
- - - - 478 173 170 177 181 192 195
Total Noncurrent Liabilities
6,876 6,883 6,869 6,969 9,248 9,406 6,253 6,320 5,800 5,024 4,757
Long-Term Debt
5,715 5,700 5,707 5,739 5,487 6,366 4,854 4,862 4,388 3,884 3,612
Noncurrent Deferred & Payable Income Tax Liabilities
257 352 238 226 219 141 157 168 147 24 65
Other Noncurrent Operating Liabilities
904 831 924 1,004 3,542 1,232 1,242 1,290 1,265 1,116 1,080
Total Equity & Noncontrolling Interests
-258 -727 -751 -865 -1,495 -661 -1,517 -2,205 -1,626 -1,383 -1,279
Total Preferred & Common Equity
-259 -729 -753 -869 -1,499 -662 -1,518 -2,206 -1,627 -1,385 -1,281
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-259 -729 -753 -869 -1,499 -662 -1,518 -2,206 -1,627 -1,385 -1,281
Common Stock
701 807 819 912 989 1,034 1,027 939 958 944 902
Retained Earnings
315 205 -1,434 -1,482 -2,182 -1,421 -1,803 -2,401 -1,838 -1,578 -1,435
Treasury Stock
-1,315 -1,753 -162 -358 -358 -358 -822 -822 -822 -822 -822
Accumulated Other Comprehensive Income / (Loss)
40 12 24 59 52 83 80 78 75 71 74
Noncontrolling Interest
1.00 2.00 2.00 4.00 4.00 1.00 1.00 1.00 1.00 2.00 2.00

Quarterly Balance Sheets for Bath & Body Works

This table presents Bath & Body Works' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/29/2023 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 5/2/2026
Total Assets
5,195 5,243 5,463 5,221 4,948 4,984 4,872 4,881 4,814 4,989 4,963
Total Current Assets
1,893 1,959 2,115 1,917 1,666 1,720 1,823 1,820 1,706 1,881 1,899
Cash & Equivalents
790 412 1,084 855 514 191 674 636 364 236 820
Accounts Receivable
153 197 224 121 146 200 205 103 131 169 98
Inventories, net
818 1,205 710 814 863 1,178 734 869 977 1,251 782
Other Current Assets
132 145 97 127 143 151 114 115 153 144 118
Other Current Nonoperating Assets
- - 0.00 0.00 0.00 0.00 96 97 81 81 81
Plant, Property, & Equipment, net
1,236 1,244 1,220 1,183 1,166 1,158 1,127 1,111 1,124 1,142 1,106
Total Noncurrent Assets
2,066 2,040 2,128 2,121 2,116 2,106 1,922 1,950 1,984 1,966 1,958
Goodwill
628 628 628 628 628 628 628 628 628 628 628
Intangible Assets
165 165 165 165 165 165 165 165 165 165 165
Noncurrent Deferred & Refundable Income Taxes
38 35 144 143 143 143 130 133 133 132 110
Other Noncurrent Operating Assets
1,235 1,212 1,191 1,185 1,180 1,170 999 1,024 1,058 1,041 1,055
Total Liabilities & Shareholders' Equity
5,195 5,243 5,463 5,221 4,948 4,984 4,872 4,881 4,814 4,989 4,963
Total Liabilities
7,349 7,367 7,089 6,897 6,666 6,732 6,255 6,331 6,361 6,581 6,094
Total Current Liabilities
1,213 1,409 1,289 1,221 1,497 1,575 1,231 1,294 1,303 1,553 1,377
Short-Term Debt
0.00 0.00 - - 313 314 - 0.00 0.00 0.00 0.00
Accounts Payable
508 627 380 403 411 510 338 452 567 781 557
Accrued Expenses
518 590 608 489 526 547 584 495 541 558 513
Current Deferred & Payable Income Tax Liabilities
0.00 0.00 120 143 61 16 117 146 1.00 21 101
Other Current Liabilities
187 192 181 186 186 188 192 201 194 193 206
Total Noncurrent Liabilities
6,136 5,958 5,800 5,676 5,169 5,157 5,024 5,037 5,058 5,028 4,717
Long-Term Debt
4,668 4,497 4,388 4,282 3,881 3,883 3,884 3,886 3,888 3,890 3,613
Noncurrent Deferred & Payable Income Tax Liabilities
168 167 147 147 45 45 24 23 23 23 115
Other Noncurrent Operating Liabilities
1,300 1,294 1,265 1,247 1,243 1,229 1,116 1,128 1,147 1,115 989
Total Equity & Noncontrolling Interests
-2,154 -2,124 -1,626 -1,676 -1,718 -1,748 -1,383 -1,450 -1,547 -1,592 -1,131
Total Preferred & Common Equity
-2,155 -2,125 -1,627 -1,677 -1,719 -1,749 -1,385 -1,451 -1,548 -1,593 -1,133
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-2,155 -2,125 -1,627 -1,677 -1,719 -1,749 -1,385 -1,451 -1,548 -1,593 -1,133
Common Stock
948 951 958 960 947 942 944 931 917 910 907
Retained Earnings
-2,358 -2,329 -1,838 -1,889 -1,918 -1,942 -1,578 -1,633 -1,716 -1,754 -1,292
Treasury Stock
-822 -822 -822 -822 -822 -822 -822 -822 -822 -822 -822
Accumulated Other Comprehensive Income / (Loss)
77 75 75 74 74 73 71 73 73 73 74
Noncontrolling Interest
1.00 1.00 1.00 1.00 1.00 1.00 2.00 1.00 1.00 1.00 2.00

Annual Metrics And Ratios for Bath & Body Works

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 204,721,605.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.17
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
1,420 1,368 1,295 930 787 1,237 1,518 1,045 1,105 983 829
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 39.35% 40.01% 39.29% 31.71%
Earnings before Interest and Taxes (EBIT)
2,268 2,090 1,718 1,242 978 1,554 1,811 1,393 1,366 1,340 1,158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,683 2,562 2,242 1,789 1,566 2,075 2,174 1,614 1,635 1,622 1,412
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,565 1,208 842 925 1,766 2,709 1,242 978 852 930 981
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,915 3,075 3,528 3,533 2,554 1,082 1,358 1,425 1,678 1,731 1,579
Increase / (Decrease) in Invested Capital
-145 160 453 5.00 -979 -1,472 276 67 253 53 -152
Book Value per Share
($0.89) ($2.55) ($2.67) ($3.16) ($5.42) ($2.38) ($5.89) ($9.66) ($7.20) ($6.39) ($6.26)
Tangible Book Value per Share
($6.87) ($8.70) ($8.90) ($9.55) ($9.18) ($5.23) ($8.97) ($13.13) ($10.71) ($10.06) ($10.13)
Total Capital
5,463 5,009 5,043 4,946 4,053 5,705 3,337 2,657 2,762 2,501 2,613
Total Debt
5,721 5,736 5,794 5,811 5,548 6,366 4,854 4,862 4,388 3,884 3,892
Total Long-Term Debt
5,715 5,700 5,707 5,739 5,487 6,366 4,854 4,862 4,388 3,884 3,612
Net Debt
3,173 3,802 4,279 4,398 4,049 2,798 2,875 3,630 3,304 3,210 2,939
Capital Expenditures (CapEx)
531 937 707 629 458 228 270 328 298 226 228
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-261 -447 -166 -67 -565 -815 -260 -345 -258 -82 -245
Debt-free Net Working Capital (DFNWC)
2,287 1,487 1,349 1,346 934 2,753 1,719 887 826 592 708
Net Working Capital (NWC)
2,281 1,451 1,262 1,274 873 2,753 1,719 887 826 592 428
Net Nonoperating Expense (NNE)
167 210 312 286 1,153 393 185 245 227 185 180
Net Nonoperating Obligations (NNO)
3,173 3,802 4,279 4,398 4,049 1,743 2,875 3,630 3,304 3,114 2,858
Total Depreciation and Amortization (D&A)
415 472 524 547 588 521 363 221 269 282 254
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $1.86 ($1.06) $2.43 $4.96 $0.00 $3.86 $3.62 $3.12
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $1.85 ($1.06) $2.40 $4.88 $0.00 $3.84 $3.61 $3.11
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 344.08M 345.75M 697.21M 238.91M 0.00 224.90M 214.23M 201.13M
Normalized Net Operating Profit after Tax (NOPAT)
1,420 1,368 1,295 1,004 787 1,237 1,518 1,045 1,105 983 829
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Bath & Body Works

This table displays calculated financial ratios and metrics derived from Bath & Body Works' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
DEI Shares Outstanding
- - - - - - - - - 204,721,605.00 201,134,265.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 204,721,605.00 201,134,265.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 1.97 0.91
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.62% 0.83% -0.86% -2.12% 3.07% -4.29% 2.89% 1.51% -0.99% - -3.23%
EBITDA Growth
19.92% 7.89% 2.65% 7.89% -7.03% -2.57% 3.69% -24.58% -19.59% - 5.34%
EBIT Growth
18.54% 6.94% -0.50% 7.98% -8.64% -2.96% 8.50% -29.13% -22.97% - 8.29%
NOPAT Growth
7.08% 33.32% 5.33% 24.05% -3.65% -22.30% 9.02% -41.82% -24.48% - 69.42%
Net Income Growth
30.77% 33.41% 7.41% 53.54% -10.92% -21.76% 20.69% -57.89% -27.36% - 74.29%
EPS Growth
30.00% 33.68% 8.57% 58.14% -5.77% -18.90% 28.95% -55.88% -24.49% - 83.67%
Operating Cash Flow Growth
-250.00% -14.02% 72.73% -239.39% -102.04% 3.13% 147.37% 6.52% 180.81% - 29.79%
Free Cash Flow Firm Growth
342.60% -5.88% -142.63% -133.74% -185.27% 14.24% 512.05% 405.66% 388.71% - 89.94%
Invested Capital Growth
0.20% 17.75% 11.89% 13.81% 15.15% 3.16% -2.74% -3.36% -12.27% - -7.16%
Revenue Q/Q Growth
0.19% 86.43% -52.47% 10.26% 5.50% 73.11% -48.91% 8.78% 2.91% - -49.41%
EBITDA Q/Q Growth
12.19% 148.88% -65.21% 11.07% -3.32% 160.82% -62.98% -19.22% 3.08% - -55.82%
EBIT Q/Q Growth
14.08% 191.77% -71.79% 15.00% -3.48% 209.91% -68.46% -24.88% 4.91% - -61.29%
NOPAT Q/Q Growth
12.86% 290.51% -78.65% 31.86% -12.34% 214.91% -70.05% -29.63% 13.80% - -43.24%
Net Income Q/Q Growth
20.20% 386.55% -84.97% 74.71% -30.26% 327.36% -76.82% -39.05% 20.31% - -54.59%
EPS Q/Q Growth
20.93% 388.46% -85.04% 78.95% -27.94% 320.41% -76.21% -38.78% 23.33% - -53.85%
Operating Cash Flow Q/Q Growth
-248.48% 1,989.80% -91.79% -160.53% -115.22% 1,064.65% -80.31% -122.87% 286.05% - -72.18%
Free Cash Flow Firm Q/Q Growth
-3.09% 143.44% -112.25% -16.77% -144.92% 426.12% -55.82% -13.38% 131.33% - -37.30%
Invested Capital Q/Q Growth
13.75% -14.43% 4.35% 12.05% 15.09% -23.34% -1.62% 11.33% 4.48% - 0.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.66% 45.88% 43.79% 41.02% 43.48% 46.72% 45.37% 41.32% 41.28% - 42.60%
EBITDA Margin
20.04% 26.75% 19.58% 19.72% 18.07% 27.23% 19.73% 14.65% 14.68% - 21.48%
Operating Margin
14.15% 23.87% 13.51% 11.99% 13.54% 24.33% 14.68% 10.14% 10.10% - 16.76%
EBIT Margin
15.56% 24.35% 14.45% 15.07% 13.79% 24.69% 15.24% 10.52% 10.73% - 17.05%
Profit (Net Income) Margin
7.62% 19.88% 6.29% 9.96% 6.58% 16.25% 7.37% 4.13% 4.83% - 13.28%
Tax Burden Percent
74.84% 92.94% 73.73% 99.35% 73.10% 74.02% 71.92% 67.37% 74.76% - 110.24%
Interest Burden Percent
65.43% 87.87% 59.00% 66.52% 65.32% 88.95% 67.28% 58.28% 60.23% - 70.64%
Effective Tax Rate
25.16% 7.06% 26.27% 0.65% 26.90% 25.98% 28.08% 32.63% 25.24% - -10.24%
Return on Invested Capital (ROIC)
40.03% 106.21% 44.56% 47.73% 34.87% 77.19% 44.90% 26.09% 26.20% - 81.54%
ROIC Less NNEP Spread (ROIC-NNEP)
38.95% 104.28% 43.14% 46.94% 33.55% 75.67% 43.53% 24.92% 25.05% - 79.10%
Return on Net Nonoperating Assets (RNNOA)
-71.21% -188.74% -80.34% -91.63% -70.12% -161.40% -91.62% -54.36% -56.85% - -179.74%
Return on Equity (ROE)
-31.18% -82.53% -35.78% -43.90% -35.24% -84.21% -46.72% -28.27% -30.65% - -98.20%
Cash Return on Invested Capital (CROIC)
47.12% 54.92% 55.80% 49.18% 40.01% 54.55% 60.41% 51.14% 54.64% - 63.78%
Operating Return on Assets (OROA)
22.21% 33.02% 20.25% 21.94% 20.04% 34.91% 22.17% 15.89% 15.82% - 25.10%
Return on Assets (ROA)
10.87% 26.96% 8.81% 14.50% 9.57% 22.98% 10.73% 6.24% 7.12% - 19.55%
Return on Common Equity (ROCE)
-31.19% -82.58% -35.80% -43.92% -35.26% -84.29% -46.75% -28.28% -30.67% - -98.31%
Return on Equity Simple (ROE_SIMPLE)
-34.49% 0.00% -52.71% -54.51% -52.83% 0.00% -56.24% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
165 646 138 182 159 502 150 106 120 449 255
NOPAT Margin
10.59% 22.18% 9.96% 11.91% 9.90% 18.01% 10.56% 6.83% 7.55% - 18.48%
Net Nonoperating Expense Percent (NNEP)
1.07% 1.93% 1.42% 0.79% 1.32% 1.52% 1.38% 1.17% 1.14% - 2.44%
Return On Investment Capital (ROIC_SIMPLE)
- 23.39% - - - 20.07% 6.17% 4.52% 5.24% 17.17% 10.26%
Cost of Revenue to Revenue
56.34% 54.12% 56.21% 58.98% 56.52% 53.28% 54.63% 58.68% 58.72% - 57.40%
SG&A Expenses to Revenue
29.51% 22.01% 30.27% 29.03% 29.94% 22.39% 30.69% 31.18% 31.18% - 25.83%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue
29.51% 22.01% 30.27% 29.03% 29.94% 22.39% 30.69% 31.18% 31.18% - 25.83%
Earnings before Interest and Taxes (EBIT)
243 709 200 230 222 688 217 163 171 607 235
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
313 779 271 301 291 759 281 227 234 670 296
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)
0.85 1.30 1.42 1.02 0.88 1.17 0.97 0.87 0.76 - 0.61
Price to Earnings (P/E)
8.58 11.01 11.88 8.05 7.10 10.71 8.73 8.78 8.00 - 6.04
Dividend Yield
2.91% 1.89% 1.74% 2.42% 2.78% 2.14% 2.56% 2.86% 3.27% - 4.16%
Earnings Yield
11.66% 9.08% 8.42% 12.43% 14.08% 9.34% 11.45% 11.39% 12.50% - 16.57%
Enterprise Value to Invested Capital (EV/IC)
5.29 7.73 7.95 5.72 4.68 6.79 6.09 5.23 4.67 - 4.54
Enterprise Value to Revenue (EV/Rev)
1.40 1.75 1.88 1.52 1.42 1.61 1.41 1.35 1.26 - 0.99
Enterprise Value to EBITDA (EV/EBITDA)
6.57 7.94 8.48 6.74 6.44 7.25 6.36 6.36 6.16 - 5.03
Enterprise Value to EBIT (EV/EBIT)
7.86 9.50 10.20 8.12 7.77 8.78 7.65 7.69 7.46 - 6.11
Enterprise Value to NOPAT (EV/NOPAT)
11.19 11.74 12.53 9.80 9.26 11.97 10.42 10.77 10.49 - 7.76
Enterprise Value to Operating Cash Flow (EV/OCF)
9.39 13.60 14.13 12.37 12.33 13.27 10.40 9.91 7.84 - 6.20
Enterprise Value to Free Cash Flow (EV/FCFF)
11.24 15.23 15.05 12.38 12.52 12.65 9.94 10.05 7.98 - 6.86
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-2.12 -2.70 -2.55 -2.44 -2.40 -2.81 -2.68 -2.51 -2.44 - -3.19
Long-Term Debt to Equity
-2.12 -2.70 -2.55 -2.26 -2.22 -2.81 -2.68 -2.51 -2.44 - -3.19
Financial Leverage
-1.83 -1.81 -1.86 -1.95 -2.09 -2.13 -2.10 -2.18 -2.27 - -2.27
Leverage Ratio
-2.19 -2.86 -2.75 -2.62 -2.64 -3.43 -3.23 -2.99 -2.99 - -3.81
Compound Leverage Factor
-1.43 -2.51 -1.62 -1.74 -1.73 -3.06 -2.17 -1.74 -1.80 - -2.69
Debt to Total Capital
189.51% 158.87% 164.31% 169.39% 171.38% 155.30% 159.52% 166.08% 169.28% - 145.57%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 12.64% 12.82% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital
189.51% 158.87% 164.31% 156.74% 158.55% 155.30% 159.52% 166.08% 169.28% - 145.57%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.04% 0.04% 0.04% 0.04% 0.04% 0.08% 0.04% 0.04% 0.04% - 0.08%
Common Equity to Total Capital
-89.55% -58.91% -64.35% -69.43% -71.42% -55.38% -59.56% -66.13% -69.32% - -45.65%
Debt to EBITDA
2.85 2.68 2.61 2.52 2.56 2.39 2.38 2.50 2.59 - 2.53
Net Debt to EBITDA
2.59 2.02 2.09 2.21 2.44 1.98 1.99 2.26 2.43 - 1.96
Long-Term Debt to EBITDA
2.85 2.68 2.61 2.33 2.36 2.39 2.38 2.50 2.59 - 2.53
Debt to NOPAT
4.85 3.97 3.85 3.67 3.68 3.95 3.90 4.22 4.42 - 3.90
Net Debt to NOPAT
4.41 2.99 3.08 3.22 3.51 3.27 3.27 3.83 4.15 - 3.02
Long-Term Debt to NOPAT
4.85 3.97 3.85 3.39 3.40 3.95 3.90 4.22 4.42 - 3.90
Altman Z-Score
1.58 2.32 2.11 1.82 1.71 2.48 1.99 1.85 1.68 - 1.81
Noncontrolling Interest Sharing Ratio
-0.04% -0.05% -0.05% -0.05% -0.05% -0.10% -0.06% -0.06% -0.06% - -0.12%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.39 1.64 1.57 1.11 1.09 1.48 1.41 1.31 1.21 - 1.38
Quick Ratio
0.43 1.01 0.80 0.44 0.25 0.71 0.57 0.38 0.26 - 0.67
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
161 393 -48 -56 -138 449 198 172 397 601 377
Operating Cash Flow to CapEx
-68.06% 1,929.17% 165.22% -83.64% -152.31% 1,591.67% 508.11% -76.79% 98.77% - 595.12%
Free Cash Flow to Firm to Interest Expense
1.92 4.57 -0.59 -0.73 -1.79 5.91 2.79 2.53 5.84 - 5.46
Operating Cash Flow to Interest Expense
-0.58 10.77 0.93 -0.60 -1.29 12.57 2.65 -0.63 1.18 - 3.54
Operating Cash Flow Less CapEx to Interest Expense
-1.44 10.21 0.37 -1.31 -2.13 11.78 2.13 -1.46 -0.01 - 2.94
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.43 1.36 1.40 1.46 1.45 1.41 1.45 1.51 1.47 - 1.47
Accounts Receivable Turnover
33.74 33.02 55.77 49.39 37.44 34.07 65.60 53.21 39.86 - 72.09
Inventory Turnover
3.44 5.91 5.26 4.92 3.49 5.64 4.84 4.44 3.38 - 4.98
Fixed Asset Turnover
6.26 6.16 6.17 6.15 6.19 6.23 6.41 6.44 6.39 - 6.54
Accounts Payable Turnover
6.76 10.04 10.06 9.00 7.32 11.35 9.53 8.35 6.36 - 8.16
Days Sales Outstanding (DSO)
10.82 11.05 6.55 7.39 9.75 10.71 5.56 6.86 9.16 - 5.06
Days Inventory Outstanding (DIO)
106.06 61.76 69.35 74.21 104.44 64.70 75.41 82.26 107.91 - 73.22
Days Payable Outstanding (DPO)
53.97 36.34 36.27 40.57 49.83 32.17 38.31 43.72 57.35 - 44.75
Cash Conversion Cycle (CCC)
62.91 36.47 39.62 41.03 64.36 43.24 42.66 45.40 59.71 - 33.54
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,961 1,678 1,751 1,962 2,258 1,731 1,703 1,896 1,981 1,579 1,581
Invested Capital Turnover
3.78 4.79 4.47 4.01 3.52 4.29 4.25 3.82 3.47 - 4.41
Increase / (Decrease) in Invested Capital
4.00 253 186 238 297 53 -48 -66 -277 -152 -122
Enterprise Value (EV)
10,374 12,975 13,928 11,220 10,570 11,760 10,375 9,916 9,247 - 7,183
Market Capitalization
6,288 9,670 10,500 7,539 6,563 8,548 7,124 6,391 5,592 - 4,388
Book Value per Share
($9.35) ($7.20) ($7.46) ($7.70) ($7.98) ($6.39) ($6.77) ($7.32) ($7.73) ($6.26) ($5.63)
Tangible Book Value per Share
($12.83) ($10.71) ($10.98) ($11.25) ($11.60) ($10.06) ($10.47) ($11.06) ($11.57) ($10.13) ($9.58)
Total Capital
2,373 2,762 2,606 2,476 2,449 2,501 2,436 2,341 2,298 2,613 2,482
Total Debt
4,497 4,388 4,282 4,194 4,197 3,884 3,886 3,888 3,890 3,892 3,613
Total Long-Term Debt
4,497 4,388 4,282 3,881 3,883 3,884 3,886 3,888 3,890 3,612 3,613
Net Debt
4,085 3,304 3,427 3,680 4,006 3,210 3,250 3,524 3,654 2,939 2,793
Capital Expenditures (CapEx)
72 48 46 55 65 60 37 56 81 63 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)
138 -258 -159 -32 268 -82 -110 39 92 -245 -298
Debt-free Net Working Capital (DFNWC)
550 826 696 482 459 592 526 403 328 708 522
Net Working Capital (NWC)
550 826 696 169 145 592 526 403 328 428 522
Net Nonoperating Expense (NNE)
46 67 51 30 53 49 45 42 43 46 72
Net Nonoperating Obligations (NNO)
4,085 3,304 3,427 3,680 4,006 3,114 3,153 3,443 3,573 2,858 2,712
Total Depreciation and Amortization (D&A)
70 70 71 71 69 71 64 64 63 63 61
Debt-free, Cash-free Net Working Capital to Revenue
1.86% -3.47% -2.14% -0.43% 3.61% -1.12% -1.50% 0.53% 1.25% - -4.11%
Debt-free Net Working Capital to Revenue
7.43% 11.12% 9.38% 6.53% 6.18% 8.10% 7.16% 5.47% 4.46% - 7.21%
Net Working Capital to Revenue
7.43% 11.12% 9.38% 2.29% 1.95% 8.10% 7.16% 5.47% 4.46% - 7.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 $2.55 $0.39 $0.68 $0.49 $2.06 $0.49 $0.31 $0.38 $1.94 $0.91
Adjusted Weighted Average Basic Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Adjusted Diluted Earnings per Share
$0.52 $2.54 $0.38 $0.68 $0.49 $2.06 $0.49 $0.30 $0.37 $1.95 $0.90
Adjusted Weighted Average Diluted Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
225.94M 224.90M 223.23M 219.11M 216.58M 214.23M 211.61M 206.19M 204.72M 201.13M 201.56M
Normalized Net Operating Profit after Tax (NOPAT)
165 646 138 182 159 502 150 106 120 449 162
Normalized NOPAT Margin
10.59% 22.18% 9.96% 11.91% 9.90% 18.01% 10.56% 6.83% 7.55% - 11.73%
Pre Tax Income Margin
10.18% 21.39% 8.53% 10.03% 9.01% 21.96% 10.25% 6.13% 6.46% - 12.05%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.89 8.24 2.44 2.99 2.88 9.05 3.06 2.40 2.51 - 3.41
NOPAT to Interest Expense
1.97 7.51 1.68 2.36 2.07 6.60 2.12 1.56 1.77 - 3.69
EBIT Less CapEx to Interest Expense
2.04 7.69 1.88 2.27 2.04 8.26 2.54 1.57 1.32 - 2.81
NOPAT Less CapEx to Interest Expense
1.11 6.95 1.12 1.65 1.23 5.81 1.60 0.73 0.58 - 3.10
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
24.97% 20.73% 20.48% 19.21% 19.37% 22.18% 21.45% 23.63% 24.18% - 22.56%
Augmented Payout Ratio
38.47% 37.59% 48.08% 56.35% 62.45% 72.43% 75.49% 79.53% 80.83% - 59.01%

Financials Breakdown Chart

Key Financial Trends

Bath & Body Works (NYSE:BBWI) showed a much improved start to fiscal 2026, but the bigger picture remains mixed. In Q1 2026, the company returned to solid profitability and generated healthy operating cash flow, yet it is still carrying a heavy debt load and shareholders’ equity remains negative. Over the last several years, BBWI has also seen revenue trend lower from its 2023 peak, even as management has worked to improve margins, control expenses, and reduce leverage.

What stands out most in the latest quarter: revenue was $1.378 billion, down from $1.424 billion in Q1 2025 and below the $1.396 billion level in Q1 2023. Even so, gross margin improved meaningfully versus the prior year, and earnings held up reasonably well. Net income came in at $183 million, up from $105 million in the prior-year quarter, while operating cash flow reached $244 million.

Positive trends

  • Q1 2026 net income rose to $183 million, up from $105 million in Q1 2025, showing better bottom-line performance.
  • Operating cash flow was strong at $244 million in Q1 2026, indicating the business continues to convert earnings into cash.
  • Gross profit improved to $587 million in Q1 2026, with gross margin around 42.6%, better than the roughly 41.2% margin in Q1 2025.
  • SG&A expense as a percentage of revenue improved year over year, suggesting better cost control.
  • Cash and equivalents increased to $820 million at the end of Q1 2026 from $674 million a year earlier.
  • Short-term debt was zero in Q1 2026, giving the company more near-term liquidity flexibility.
  • BBWI continued to generate positive earnings in each quarter shown, even during weaker sales periods.
  • The company has been reducing debt over time, including a $292 million repayment in Q1 2026.

Neutral trends

  • Revenue has been volatile, but Q1 2026 sales of $1.378 billion were only modestly below Q1 2025 and Q1 2023 levels.
  • Capital spending remains relatively controlled, with Q1 2026 capex at $49 million.
  • Dividend payments continue, with $40 million paid in Q1 2026, showing management is still returning some cash to shareholders.
  • Inventory ended Q1 2026 at $782 million, down from $869 million in Q1 2025, which may reflect tighter stock management rather than a major demand shift.
  • The balance sheet still shows negative common equity, which is not unusual for heavily repurchased companies but still warrants attention.

Negative trends

  • Revenue has declined from the company’s 2023 highs, signaling a softer top-line trend over the last several years.
  • Long-term debt remains very high at $3.613 billion in Q1 2026, limiting financial flexibility.
  • Total liabilities of $6.094 billion still far exceed total assets of $4.963 billion, leaving shareholders’ equity deeply negative.
  • Net income fell sharply from Q4 2025’s $403 million, though that quarter is seasonally much stronger.
  • Operating cash flow in Q1 2026 was supported in part by working-capital changes, so it is not entirely driven by underlying profitability.
  • The company spent $335 million on financing outflows in Q1 2026, mainly debt repayment and dividends, which keeps cash pressure elevated.
  • Compared with 2024, Q1 2025 and 2025 quarterly results showed more pressure on operating cash flow, especially in the middle part of the year.

Bottom line: BBWI’s latest quarter suggests the business is stabilizing, with better earnings, improved margins, and solid cash generation. However, investors should not ignore the company’s still-heavy leverage, negative equity position, and the fact that revenue has not yet returned to its earlier peak levels. For retail investors, BBWI looks like a company with improving operational discipline, but the balance sheet remains the key risk to watch.

06/16/26 07:59 AM ETAI Generated. May Contain Errors.

Bath & Body Works Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bath & Body Works' financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Bath & Body Works' net income appears to be on a downward trend, with a most recent value of $649 million in 2025, falling from $1.25 billion in 2015. The previous period was $798 million in 2024. View Bath & Body Works' forecast to see where analysts expect Bath & Body Works to go next.

Bath & Body Works' total operating income in 2025 was $1.13 billion, based on the following breakdown:
  • Total Gross Profit: $3.19 billion
  • Total Operating Expenses: $2.06 billion

Over the last 10 years, Bath & Body Works' total revenue changed from $12.15 billion in 2015 to $7.29 billion in 2025, a change of -40.0%.

Bath & Body Works' total liabilities were at $6.35 billion at the end of 2025, a 1.5% increase from 2024, and a 27.5% decrease since 2015.

In the past 10 years, Bath & Body Works' cash and equivalents has ranged from $674 million in 2024 to $3.57 billion in 2020, and is currently $953 million as of their latest financial filing in 2025.

Over the last 10 years, Bath & Body Works' book value per share changed from -0.89 in 2015 to -6.26 in 2025, a change of 599.3%.



Financial statements for NYSE:BBWI last updated on 5/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners